118 related articles for article (PubMed ID: 10406829)
1. Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia.
Hasdai D; Nielsen MF; Rizza RA; Holmes DR; Richardson DM; Cohen P; Lerman A
Hypertension; 1999 Jul; 34(1):89-95. PubMed ID: 10406829
[TBL] [Abstract][Full Text] [Related]
2. Insulin and insulin-like growth factor-I cause coronary vasorelaxation in vitro.
Hasdai D; Rizza RA; Holmes DR; Richardson DM; Cohen P; Lerman A
Hypertension; 1998 Aug; 32(2):228-34. PubMed ID: 9719047
[TBL] [Abstract][Full Text] [Related]
3. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia.
Mathew V; Cannan CR; Miller VM; Barber DA; Hasdai D; Schwartz RS; Holmes DR; Lerman A
Circulation; 1997 Sep; 96(6):1930-6. PubMed ID: 9323083
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering.
Wilson SH; Simari RD; Best PJ; Peterson TE; Lerman LO; Aviram M; Nath KA; Holmes DR; Lerman A
Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):122-8. PubMed ID: 11145943
[TBL] [Abstract][Full Text] [Related]
5. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia.
Sorop O; van den Heuvel M; van Ditzhuijzen NS; de Beer VJ; Heinonen I; van Duin RW; Zhou Z; Koopmans SJ; Merkus D; van der Giessen WJ; Danser AH; Duncker DJ
Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1339-H1351. PubMed ID: 27591223
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size.
Oltman CL; Kane NL; Gutterman DD; Bar RS; Dellsperger KC
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E176-81. PubMed ID: 10893337
[TBL] [Abstract][Full Text] [Related]
7. The effect of basic fibroblast growth factor on coronary vascular tone in experimental hypercholesterolemia in vivo and in vitro.
Hasdai D; Mathew V; Schwartz RS; Holmes DR; Lerman A
Coron Artery Dis; 1997 May; 8(5):299-304. PubMed ID: 9285183
[TBL] [Abstract][Full Text] [Related]
8. Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c.
Hasdai D; Holmes DR; Richardson DM; Izhar U; Lerman A
Cardiovasc Res; 1998 Sep; 39(3):644-50. PubMed ID: 9861307
[TBL] [Abstract][Full Text] [Related]
9. Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization: contribution of nitric oxide and Ca2+-activated K+ channels.
Miura H; Liu Y; Gutterman DD
Circulation; 1999 Jun; 99(24):3132-8. PubMed ID: 10377076
[TBL] [Abstract][Full Text] [Related]
10. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function.
Zhang C; Hein TW; Wang W; Kuo L
Circ Res; 2003 Feb; 92(3):322-9. PubMed ID: 12595345
[TBL] [Abstract][Full Text] [Related]
11. Hypercholesterolemia abolishes voltage-dependent K+ channel contribution to adenosine-mediated relaxation in porcine coronary arterioles.
Heaps CL; Tharp DL; Bowles DK
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H568-76. PubMed ID: 15458946
[TBL] [Abstract][Full Text] [Related]
12. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
Wilson SH; Best PJ; Lerman LO; Holmes DR; Richardson DM; Lerman A
Cardiovasc Res; 1999 Dec; 44(3):601-7. PubMed ID: 10690293
[TBL] [Abstract][Full Text] [Related]
13. Increased coronary effects of stimulation of endothelin-B receptor in experimental hypercholesterolemia.
Mathew V; Miller VM; Hasdai D; Barber DA; Holmes DR; Lerman A
Coron Artery Dis; 2000 Dec; 11(8):585-92. PubMed ID: 11107505
[TBL] [Abstract][Full Text] [Related]
14. Acidosis-induced coronary arteriolar dilation is mediated by ATP-sensitive potassium channels in vascular smooth muscle.
Ishizaka H; Kuo L
Circ Res; 1996 Jan; 78(1):50-7. PubMed ID: 8603505
[TBL] [Abstract][Full Text] [Related]
15. Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro.
Best PJ; Lerman LO; Romero JC; Richardson D; Holmes DR; Lerman A
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2769-75. PubMed ID: 10559024
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine.
Kuo L; Davis MJ; Cannon MS; Chilian WM
Circ Res; 1992 Mar; 70(3):465-76. PubMed ID: 1537085
[TBL] [Abstract][Full Text] [Related]
17. Exercise attenuates the effects of hypercholesterolemia on endothelium-dependent relaxation in coronary arteries from adult female pigs.
Woodman CR; Turk JR; Rush JW; Laughlin MH
J Appl Physiol (1985); 2004 Mar; 96(3):1105-13. PubMed ID: 12959954
[TBL] [Abstract][Full Text] [Related]
18. Flow-induced dilation of human coronary arterioles: important role of Ca(2+)-activated K(+) channels.
Miura H; Wachtel RE; Liu Y; Loberiza FR; Saito T; Miura M; Gutterman DD
Circulation; 2001 Apr; 103(15):1992-8. PubMed ID: 11306529
[TBL] [Abstract][Full Text] [Related]
19. Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro.
Izhar U; Hasdai D; Richardson DM; Cohen P; Lerman A
Coron Artery Dis; 2000 Feb; 11(1):69-76. PubMed ID: 10715809
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation in vivo.
Yada T; Shimokawa H; Hiramatsu O; Haruna Y; Morita Y; Kashihara N; Shinozaki Y; Mori H; Goto M; Ogasawara Y; Kajiya F
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1138-46. PubMed ID: 16648191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
